SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2019 Biotech Charity Contest
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (110)2/14/2019 4:00:27 PM
From: keokalani'nui   of 280
 
Re: CMRX ceo



From a local paper. This would seem to rule out ‘for cause’, such a scientific misconduct, and clearly preserves her potential rewards for contributions to the clinical program. I read this as positive if separation is indeed unrelated to brinci, though the SP is still sinking.



finance.yahoo.com





Following former Chimerix CEO Michelle Berrey’s sudden resignation, the company has detailed her severance package this week in an SEC filing.

In early February, the Durham pharmaceutical company (Nasdaq: CMRX) announced Berrey's immediate resignation. She had served as CEO since 2014. In addition to her executive role, Berrey also resigned as a member of the board, severing her official ties to Chimerix.

The company’s latest filing shows Berrey received a salary of $541,719 in 2017, with a total compensation package of $2.1 million. The year prior, her total compensation was over $4 million.

According to the filing, Berrey will continue to receive her base salary contribution for 18 months, as well as accelerated vesting of all outstanding time-based stock options and other time-based stock awards as if she had completed service for an additional 15 months. She will also continue to be covered by company benefits for the same time period.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News